|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Arizona Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing ArizonaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Amneal Pharmaceuticals, Inc.
| | | Phone: | (215) 558-4300 | Fax: | (215) 558-4333 | Year Established: | 1999 | Ticker: | AMRX | Exchange: | NYSE | Main Contact: | Robert Stewart, President & CEO | | Other Contacts: | Bryan M. Reasons, Senior VP & CFO Deb M. Penza, Senior VP, Chief Compliance Officer Sheldon Hirt, Senior VP, General Counsel Scott L. Hunter, VP, Specialty Sales and Marketing Shankar Hariharan, Ph.D., Executive VP & CSO Miguel Gomez, Senior VP, Technical Operations Joseph Greer, Senior VP, Global Quality Management Andrew S. Boyer, Executive VP, Commercial Operations Robert Stewart, President
| | Company Description | Amneal Pharmaceuticals, formerly Impax Laboratories, is a U.S.-based developer and manufacturer of high quality generic pharmaceuticals globally. The Company owns and operates manufacturing, R&D, packaging, sales and distribution facilities throughout the U.S. and abroad. | |
|
|
|
|
|